GlassScriptPhysician profile
James Bruce Baldwin
NPI 1588928444
$7,580.14
in general payments reported to CMS, 2019-2025
25 companies · $766 in 2025
The $766 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,653 · 2020: $1,115 · 2021: $927 · 2022: $1,090 · 2023: $829 · 2024: $201 · 2025: $766.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,741 · Debt Forgiveness: $54.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,741.23 |
| Debt Forgiveness | $54.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,322.39 | 2019-2025 | T2, Augment Injectable, Prophecy |
| Arthrosurface Incorporated | $1,234.56 | 2019 | |
| Horizon Therapeutics Plc | $592.04 | 2022-2023 | Krystexxa |
| Melinta Therapeutics, LLC | $469.39 | 2019-2021 | |
| Smith+Nephew, INC. | $417.27 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $295.60 | 2022-2024 | Nuzyra |
| Medshape, INC. | $273.66 | 2019-2020 | |
| Medline Industries LP | $219.99 | 2020-2021 | |
| Integra Lifesciences Corporation | $215.49 | 2021-2022 | |
| Sandoz INC. | $210.68 | 2019-2021 | |
| Osteomed LLC | $176.46 | 2019 | |
| Kci USA, INC. | $165.70 | 2019-2020 | |
| Depuy Synthes Sales INC. | $147.30 | 2025 | Dynaforce, Na |
| Misonix INC | $135.28 | 2019-2020 | |
| Cardiovascular Systems INC. | $123.80 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $112.90 | 2022 | |
| Averitas Pharma INC. | $85.49 | 2023 | Qutenza |
| Axogen | $82.97 | 2023-2025 | Avance Nerve Graft |
| Organogenesis INC. | $69.62 | 2019-2020 | |
| Bioventus LLC | $62.77 | 2020 | |
| Djo, LLC | $54.45 | 2023 | |
| Avanos Medical | $37.79 | 2019 | |
| Trilliant Surgical LLC. | $35.72 | 2019 | |
| Merck Sharp & Dohme LLC | $27.28 | 2019 | |
| Mayne Pharma Commercial LLC | $11.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Baldwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.